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ABSTRACT
Background The differences in gastric cancer be-
tween East and West have been frequently discussed. 
However, there are few studies that have compared 
Japan and China in Asia.
Methods Patient characteristics, surgical procedures 
and pathologic information were compared among 
gastric cancer patients who underwent curative-intent 
gastrectomy at two large volume cancer centers in 
China and Japan.
Results The median age of Japanese patients is 
70 years, seven years older than those in China, and 
more than 25% of Japanese patients were older than 
75. In China, the tumor was thicker, and lymph node 
metastasis was frequently observed. Total gastrectomy 
was more common in China (35.6% vs 21.9%). Distal 
gastrectomy rate was 56.0 percent in Japan, compared 
to 42.2 percent in China. The proportion of patients 
undergoing proximal gastrectomy was almost equal in 
China and Japan. Further analysis of the characteristics 
of patients undergoing total gastrectomy revealed that 
in China, more advanced gastric cancer patients with 
larger tumors and more lymph node metastasis under-
went total gastrectomy, while in Japan, more early stage 
gastric cancer patients underwent total gastrectomy.
Conclusion There are some differences in gastric 
cancer between Japan and China. China needs to learn 
from Japan by establishing some screening programs 
for the diagnosis and treatment of early gastric cancer.
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Although the incidence of gastric cancer in the world is 
declining year by year, gastric cancer remains the third 
leading cause of cancer death in the world and continues 
to be a major public health problem.1 In Japan, gastric 
cancer is the second most common cancer, with nearly 
46,000 deaths annually.2 In China, every year there are 
221,478 deaths due to gastric cancer, approximately half 
of the world’s total gastric cancer deaths.3
Surgery is the most effective approach in increas-
ing the long-term survival of gastric cancer patients.4 
Surgeons in Japan mainly focus on the treatment of 
early stage gastric cancer, while in China, doctors are 
facing more advanced gastric cancer. As a result, the 
overall 5-year survival rate in China remains at 30%, 
while it has reached 63.8%–77.2% in Japan.5, 6
Due to the different stages of gastric cancer, surgi-
cal skills of doctors and patients’ different attitudes to 
the disease, there are some differences in gastric cancer 
surgery between China and Japan. We provided data 
of gastric cancer patients from two large institutions 
following radical resection to compare patient charac-
teristics, surgical procedures and pathologic information 
in China and Japan.
MATERIALS AND METHODS
Patients
All patients were diagnosed and treated at Tottori 
University from 2005 to 2013 and the first affiliated 
hospital of Xi’an Jiaotong University from 2018 to 
2019. Both institutions maintain databases of gastric 
cancer patients which collect variables including age, 
sex, surgical procedure, tumor size, depth of invasion, 
number of positive and retrieved lymph nodes, distance 
metastasis. According to the sixth edition of TNM clas-
sification system (AJCC/UICC, 2002), the TNM stage 
was reconfirmed with original information.7
Surgical procedures and pathological examination
Curative resection was performed with a negative mar-
gin, usually 3 cm or more. Frozen section pathology was 
selectively used during operation. Intraoperative finding 
of peritoneal metastasis indicated palliative resection. 
Pathological review was performed by at least two 
dedicated gastric cancer pathologists at both centers.
Statistical Analysis
All analyses were performed using SPSS 16.02 (SPSS, 
Chicago, IL). A chi-square test or a Wilcoxon rank sum 
test was used to compare patient demographic, surgical 
and pathological variables. P values less than 0.05 were 
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A total of 452 Japanese and 436 Chinese patients who 
underwent R0 resection were identified. The majority 
of enrolled patients were male. The number of male pa-
tients in China was slightly higher than those in Japan. 
Patients in Japan had a median age of 70 years, seven 
years older than those in China, and more than 25% of 
Japanese patients were older than 75, while in China, it 
was only 5.5% (Table 1).
Pathological characteristics
There were significant differences in terms of tumor 
size, T stage, N stage and TNM stage between Japan 
and China. In China, the tumor was larger, thicker, and 
more frequent lymph node metastasis was observed. 
Early stage gastric cancer was 15.4 percent in China 
and 68.6 percent in Japan. There was no significant dif-
ference in lymphadenectomy between Japan and China 
(Table 2).
Surgical characteristics
Total gastrectomy was more common in China (35.6% 
vs 21.9%). Distal gastrectomy rate was 56.0 percent 
in Japan, compared with 42.2 percent in China. The 
proportion of patients undergoing proximal gastrectomy 
was comparable between the two institutions (Table 3).
Surgical characteristics patients undergoing total 
gastrectomy
Further analysis of the characteristics of patients under-
going total gastrectomy revealed that in China, more 
advanced gastric cancer patients with larger tumors and 
more lymph node metastasis underwent total gastrec-
tomy, while in Japan, more early stage gastric cancer 
patients underwent total gastrectomy (Table 4).
DISSCUSION
By comparing the two large gastric cancer hospitals in 
Japan and China, we found some significant differences 
in patient characteristics, surgical procedures and patho-
logical information. In our reports of both Japan and 
China, there are more men with gastric cancer, which 
may be caused by diet, work stress, genetic background, 
drinking, and smoking.8, 9 In addition, older people 
were dominant in the stomach cancer population in 
Japan compared to China, which may be partly because 
in China, older patients with gastric cancer do not 
choose surgical treatment for various reasons, such as 
economic and physical condition, and family members’ 
choice.10
In Japan, early stage gastric cancers accounted for 
68.6 percent of patients, much higher than 15.4 percent 
in China. More and more studies highlighted the 
importance of the access to diagnostic and therapeutic 
facilities in developing countries.11–13 Analysis among 
Japanese patients also indicated that improving survival 
rate is closely related to more detection of early-stage 
gastric cancer patients.14 Unfortunately, Chinese pa-
tients, especially those in rural areas, they don’t attach 
importance to physical examinations and are unwilling 
to see a doctor until the appearance of severe symptoms.
Lymph node status is one of the most important 
clinical outcome determinants in gastric cancer patients. 
There was more total gastrectomy in China (35.6% vs 
21.9%) due to the later stage of gastric cancer. In Japan, 




No. of patients 436 452
Male 345 (79.1) 330 (73.0)
0.033*
Female 91 (20.9) 122 (27.0)
Age (yr)
< 30 2 (0.5) 3 (0.7)
< 0.001†
30–75 410 (94.0) 331 (73.2)
> 75 24 (5.5) 118 (26.1)
Median (range) 63 (26–82) 70 (28–93)
*Chi-square test used for categorical variables
†Wilcoxon rank sum test used for continuous variables
yr, years.
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more patients with early gastric cancer underwent total 
gastrectomy because of the location of the tumor, while 
in China, more patients with gastric cancer underwent 
total gastrectomy because of the size of the tumors. 
But how much benefit total gastrectomy can bring to 
patients with advanced gastric cancer remains to be 
confirmed.
There are still several limitations in our study. 
Firstly, due to its retrospective nature, our study may 
have a selection bias. Moreover, our data do not include 
operative time, bleeding volume and surgical approach 
(thoracotomy or laparotomy) to further analysis. Finally, 
Table 2. Pathologic and surgical characteristics
Country
P-value
China (N = 436) Japan (N = 452)
Tumor size (cm)
< 0.001
< 4 71 (16.3) 278 (61.5)
4–7 173 (39.7) 125 (27.7)
> 7 192 (44.0) 49 (10.8)
T stage
< 0.001
T1 47 (10.8) 284 (62.8)
T2 92 (21.1) 54 (11.9)
T3 100 (22.9) 88 (19.5)
T4 197 (45.2) 26 (5.8)
N stage
< 0.001
N0 96 (22.0) 344 (76.1)
N1 37 (8.5) 35 (7.7)
N2 190 (43.6) 45 (10.0)
N3 113 (25.9) 28 (6.2)
TNM stage
< 0.001
I 67 (15.4) 310 (68.6)
II 92 (21.1) 82 (18.2)
III 271 (62.1) 53 (11.7)
IV 6 (1.4) 7 (1.5)
Lymphadenectomy
0.249
D1 254 (58.3) 267 (59.2)
D2 132 (30.3) 125 (27.7)
Others 8 (1.8) 18 (4.0)
Unknown 42 (9.6) 41 (9.1)
Table 3. Surgical characteristics
Country
P-value
China (N = 436) Japan (N = 452)
Surgical procedure
< 0.001
Distal gastrectomy 184 (42.2) 253 (56.0)
Total gastrectomy 155 (35.6) 99 (21.9)
Proximal gastrectomy 93 (21.3) 90 (19.9)
Others 4 (0.9) 10 (2.2)
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our study did not include follow-up data and we could 
not assess the outcomes of treatment.
In conclusion, earlier diagnosis of gastric cancer 
can improve survival rate. China needs to learn from 
Japanese experience by establishing some screening 
programs for the diagnosis and treatment of early 
gastric cancer. Furthermore, in order to reduce the 
incidence rate of gastric cancer, it is essential to change 
the traditional routine and lifestyle in China, especially 
in the rural areas. Finally, cooperation between Chinese 
and Japanese doctors is important to improve therapeu-
tic effect of gastric cancer
The authors declare no conflict of interest.
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